Vanguard Capital Management
GNPX icon

Vanguard Capital Management’s Genprex GNPX Stock Holding History

Vanguard Capital Management’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9K Buy
1,652
+1,382
+512% +$26.5K ﹤0.01% 4014
2026
Q1 		$10.8K Buy
+270
New +$12.9K ﹤0.01% 4015

Other funds holding GNPX

Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EGM
Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return
MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
CVM
Cheviot Value Management Beverly Hills, California $984M AUM 24.46% 1-Year Est. Return

Vanguard Capital Management's GNPX Position: Q2 2026 in Review

Vanguard Capital Management increased its Genprex (GNPX) stake by 512% in Q2 2026, buying an estimated $26.5K and bringing the position to 1,652 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4014.

Vanguard Capital Management first reported a position in GNPX in Q1 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.

  • Vanguard Capital Management held 1,652 shares of Genprex worth $18.9K as of Q2 2026.
  • Vanguard Capital Management bought 1,382 Genprex shares in Q2 2026, an estimated $26.5K.
  • Genprex made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #4014 holding.
  • Vanguard Capital Management first reported a position in Genprex in Q1 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held Genprex as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.